SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from MESOBLAST (MESO) — Jan 12, 2026

MESOBLAST LTD
Date: Jan. 12, 2026 · CIK: 0001345099 · Accession: 0001213900-26-003200

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292498

Date
January 12, 2026
Author
Mesoblast Limited
Form
CORRESP
Company
MESOBLAST LTD

Letter

Mesoblast Limited

Level 38, 55 Collins Street

Melbourne, VIC 3000

Australia

January 12, 2026

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

via EDGAR

RE: Mesoblast Limited

Registration Statement on Form F-3

Filed: December 30, 2025

Securities Act File No.: 333-292498

Request for Acceleration of Effectiveness

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, Mesoblast Limited (the "Registrant") hereby respectfully requests acceleration of its Registration Statement on Form F-3 (File No. 333-292498), initially filed on December 30, 2025, so that it will become effective at 9:00 a.m. (Eastern time) on January 14, 2026, or as soon as practicable thereafter.

If you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant's outside counsel, at andrew.reilly@rimonlaw.com.

The Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the "Commission") declares the filing effective, such action:

(i) does not foreclose the Commission from taking any action with respect to the filing;

(ii) does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

(iii) may not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very truly yours,
Mesoblast Limited

Show Raw Text
CORRESP
 1
 filename1.htm

 Mesoblast Limited

 Level 38, 55 Collins Street

 Melbourne, VIC 3000

 Australia

 January 12, 2026

 Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, DC 20549

 via EDGAR

 RE:
 Mesoblast Limited

 Registration Statement on Form F-3

 Filed: December 30, 2025

 Securities Act File No.:
333-292498

 Request for Acceleration of Effectiveness

 Ladies and Gentlemen:

 Pursuant to Rule 461 under the Securities
Act of 1933, Mesoblast Limited (the "Registrant") hereby respectfully requests acceleration of its Registration Statement
on Form F-3 (File No. 333-292498), initially filed on December 30, 2025, so that it will become effective
at 9:00 a.m. (Eastern time) on January 14, 2026, or as soon as practicable thereafter.

 If you have any questions, or require any
additional information, please do not hesitate to email Andrew Reilly, the Registrant's outside counsel, at andrew.reilly@rimonlaw.com.

 The Registrant hereby acknowledges that, if
the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the "Commission") declares
the filing effective, such action:

 (i)
 does not foreclose the Commission from taking any action with respect to the filing;

 (ii)
 does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 (iii)
 may not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 Very truly yours,

 Mesoblast Limited

 By:
 /s/ Andrew Chaponnel

 Andrew Chaponnel

 Head of Finance